Journal of Antibiotics
Published by Springer Nature
ISSN : 0021-8820 eISSN : 1881-1469
Abbreviation : J. Antibiot.
Aims & Scope
The Journal of Antibiotics seeks to promote research on antibiotics and related types of biologically active substances and publishes Articles, Review Articles, Brief Communication, Correspondence and other specially commissioned reports.
The Journal of Antibiotics accepts papers on biochemical, chemical, microbiological and pharmacological studies.
However, studies regarding human therapy do not fall under the journal’s scope.
Contributions regarding recently discovered antibiotics and biologically active microbial products are particularly encouraged.
Topics of particular interest within the journal's scope include, but are not limited to, those listed below: Discovery of new antibiotics and related types of biologically active substances Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related types of biologically active substances Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related types of biologically active substances Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substances Newly found properties, mechanisms of action and resistance-development of antibiotics and related types of biologically active substances.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 2.7 |
2024 | 2.10 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.481 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
h-index
Year | Value |
---|---|
2024 | 96 |
Journal Rank
Year | Value |
---|---|
2024 | 11964 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 696 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
Citation: 1197
Authors: CLAUDE, ALICIA, S. N.
-
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.
Citation: 926
Authors: TORU, HIROSHI, MICHISANE, MICHIHISA, TOSHIO, MASAKUNI, MASANOBU, HATSUO, HIROSHI
-
Thoughts and facts about antibiotics: Where we are now and where we are heading
Citation: 848
Authors: János
-
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
Citation: 809
Authors: TORU, HIROSHI, SUSUMU, NORIAKI, MICHIHISA, TOSHIMI, TOSHIO, MASAKUNI, MASANOBU, HATSUO, TAKENORI
-
Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.
Citation: 764
Authors: S. N., H., Claude
-
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
Citation: 759
Authors: AKIRA, MASAO, YOSHIO
-
Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes.
Citation: 580
Authors: HAMAO, TAKAAKI, HIROYUKI, MASA, TOMIO
-
A new alkaloid AM-2282 of Streptomyces origin taxonomy, fermentation, isolation and preliminary characterization.
Citation: 569
Authors: SATOSHI, YUZURU, ATSUSHI, AKIRA, JUICHI, HISAE, YOKO, ROKUROU